Skip to content

CING

Cingulate Inc.

NASDAQ · Healthcare · Biotechnology · US

$4.36
+0.00%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
7.17x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
2.70x
Price / sales
—
Price / cash flow
-3.07x

Enterprise value

Enterprise value
$41.3M
EV / sales
—
EV / EBITDA
-1.67x
EV / EBIT
-1.66x
Market cap
$63.4M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026